UNSPSC 51161515: Montelukast

This classification denotes a bronchodilator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MHM278SD3E. European Medicines Agency schedules Montelukast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09054MIG. Montelukast generally arises in the molecular formula C35H36CLNO3S.

UNSPSC 51161515 Montelukast is a Commodity code that in practice does not align with the recent state and local procurement activity tagged under it. The single recent opportunity in the source—Seminole County, Florida's IFB 60459723LAS for naloxone and drug deactivation systems—bears no relationship to montelukast, an asthma and allergy maintenance medication. The mismatch suggests either a miscoding in the county's procurement system or a data error in the source material. No other recent state and local opportunities under this code are present in the source material.

Seminole County posted the naloxone solicitation on June 30, 2026, with a response deadline of July 26, 2023 (an apparent date error in the source). The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors were required to submit electronic bids through the county's e-Procurement Portal, include all shipping and delivery costs, maintain specified insurance coverage, and comply with E-Verify and drug-free workplace requirements. The contract offered an initial two-year term with a one-year renewal option and was potentially funded through FEMA. Because montelukast procurement does not appear in recent state and local solicitations under this code, business development professionals should verify the code assignment before committing resources to track activity here.